NCT02068027View on ClinicalTrials.gov

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Painful Diabetic NeuropathyDiabetic NeuropathyNeuropathy
Interventions
DRUG

Clonidine Gel 0.1%

DRUG

Placebo

Trial Locations (23)

23451

Virginia Beach

27103

Winston-Salem

29464

Mt. Pleasant

31904

Columbus

33143

Miami

33401

West Palm Beach

33458

Jupiter

33511

Brandon

33606

Tampa

34205

Bradenton

47714

Evansville

63042

Hazelwood

66160

Kansas City

75230

Dallas

77055

Houston

78229

San Antonio

85023

Phoenix

90404

Santa Monica

94598

Walnut Creek

98057

Renton

06460

Milford

06708

Waterbury

02886

Warwick

Sponsors
All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY